Replay available

Exagen Inc. (XGN) Q4 2025 Earnings Call

Exagen Inc. (NASDAQ: XGN) Q4 2025 earnings conference call, held 2026-03-10. Replay captured from the company's public earnings webcast.

Tue, March 10, 2026 at 8:30 AMendedReplay
Exagen Inc. (XGN) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Tina Jacobson

Vice President, Investor Relations

John Ibali

President and Chief Executive Officer

Jeff Black

Chief Financial Officer

Dan Brennan

Analyst, TD Cowan

Kyle Mixon

Analyst, Canaccord Genuity

Bill Vanilla

Analyst, Craig Helm

Mark Massaro

Analyst, BTIG

Matthew Parisi

Analyst, KeyBank Capital Markets

Andrew Brackman

Analyst, William Blair

Replay transcript excerpt

Greetings. Welcome to Exogen Incorporated's fourth quarter 2025 earnings call. At this time, all participants are in listen-only mode. Question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero from your telephone keypad. Please note that this conference is being recorded. At this time, I'll turn the conference over to Tina Jacobson, Vice President of Investor Relations. Thank you, Tina. You may now begin. Good morning, and thank you for joining us. Earlier this morning, Exogen released financial results for the quarter ended December 31, 2025. John Abali, our President and Chief Executive Officer, and Jeff Black, our Chief Financial Officer, will host this morning's call. The recording of today's call and the press release announcing the quarterly results can be found on the company's website at www.exogen.com. As today's call includes forward-looking statements, we encourage you to review the statements contained in today's press release and the risks and uncertainties described in our SEC filings, which identify certain factors that may cause the company's actual events, performance, and results to differ materially from those contained in the forward-looking statements made on today's call. In addition, we will discuss non-GAAP financial measures on this call. Descriptions of those non-GAAP financial measures and the reconciliations of GAAP to non-GAAP financial measures are included in today's press release. With that, I'll turn the call over to John Ibali, our President and CEO. Good morning, everyone, and thanks for joining the call today to review our 2025 performance. Before we get into the details, I wanted to start with why what we are working toward matters so...

More from Exagen Inc.